Cooperative Agreement R44CA183169

Lumo Imaging LLC received a $255,999 Small Business Technology Transfer Phase I Project Grant from the National Science Foundation Engineering Directorate to develop dermatologist-level detection of suspicious pigmented skin lesions from high-resolution full-body images. Under this one-year award beginning August 1, 2021, Lumo Imaging will utilize $255,999 to deliver products and services focused on using machine learning and computer vision techniques to analyze full-body skin images and detect...

The Sloan-Kettering Institute for Cancer Research was awarded a $1,197,158 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the early detection of melanoma using generalized and reliable AI techniques. The grant term runs from June 15, 2024 to June 14, 2027. The research involves collaboration between investigators at Sloan-Kettering, Northeastern University, Melanoma Institute Australia, and Fundació de...

The National Cancer Institute (NCI) awarded a $700,611 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to the Sloan-Kettering Institute for Cancer Research. The grant, titled "Practical Randomized Controlled Trial of Artificial Intelligence for Melanoma Diagnosis (PRACTA-MEL)," aims to determine the benefits and barriers to clinical adoption of AI systems for improving melanoma detection and reducing the number of unnecessary biopsies. The project...

Radiosight LLC was awarded a $256,000 Small Business Technology Transfer (STTR) Phase I Project Grant by the National Science Foundation on May 1, 2021 to develop a point-of-care skin cancer imaging device. The award is being carried out under the NSF's Technology, Innovation, and Partnerships program (CFDA 47.084) and will support Radiosight's efforts to advance science and engineering research leading to breakthrough technologies. Specifically, the funding will allow Radiosight to work towards...

This National Science Foundation Project Grant of $495,000 will support the development of biopsy-free, label-free three-dimensional virtual histology of intact skin through March 2025. Funded under the Engineering program (CFDA 47.041), the award to the University of California, Los Angeles aims to advance a machine learning-based technique to transform 3D skin images into virtually stained images that can facilitate accurate and rapid diagnosis of skin lesions without biopsy. Specifically, the...

Federal Project Grant Award Summary Boston University received a $569,926 project grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective August 1, 2025, with completion targeted for April 30, 2029. The award funds development of a handheld spatial frequency domain imaging (SFDI) device utilizing spiral illumination technology for non-invasive...

Visikol Inc. received a $4,103,265 Project Grant award from the National Cancer Institute, a division of the Department of Health and Human Services, under the Cancer Detection and Diagnosis Research program (CFDA 93.394). The award will support the development of a 3D imaging diagnostic tool to improve characterization of metastatic melanoma in sentinel lymph node biopsies. Visikol will conduct a retrospective clinical study using archived negative sentinel lymph node biopsy tissue blocks to...

The National Science Foundation (NSF) Division of Chemical, Bioengineering, Environmental, and Transport Systems awarded a $300,000 EAGER (Early-Concept Grants for Exploratory Research) project grant to The Research Foundation for The State University of New York (RF SUNY) to establish near-ultraviolet (NUV) coherent anti-Stokes Raman scattering (CARS) microscopy for highly sensitive imaging of native biomolecules. This technology will be applied to develop label-free digital pathology for brain...

The National Science Foundation (NSF) awarded a $650,000 Project Grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to the University of Illinois for the development of a bioinspired multispectral imaging sensor to support real-time intraoperative detection of cancer. The award aims to create a novel sensor that integrates perovskite nanocrystals and optical metasurfaces to simultaneously detect endogenous cancer biomarkers in the UV spectrum and exogenous markers...

This Cooperative Agreement award for $310,185.00 from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) supports research by New York University School of Medicine to analytically and clinically validate an Epic 900K V2 array-based methylation assay for predicting recurrence in stage II melanoma. The project aims to refine and validate a 13-probe signature that was previously found to accurately identify melanoma recurrence and mortality among stage II...